Acceleron Pharma Lands $30,000,000 New Financing

  • Feed Type
  • Date
    12/23/2011
  • Company Name
    Acceleron Pharma
  • Mailing Address
    128 Sidney Street Cambridge, MA 02139
  • Company Description
    Acceleron is establishing itself as the premier company in GDF-targeted therapies. We have developed an unparalleled expertise in GDF biology, and our scientific advisory board consists of leaders and pioneers in the field.
  • Website
    http://www.acceleronpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $30,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The proceeds will be used to expand and advance Acceleron’s clinical stage pipeline and to continue to support its highly productive research engine.
  • M&A Terms
  • Venture Investor
    Celgene Corporation
  • Venture Investor
    Advanced Technology Ventures
  • Venture Investor
    Avalon Ventures
  • Venture Investor
    Bessemer Venture Partners
  • Venture Investor
    Flagship Ventures
  • Venture Investor
    MPM Capital
  • Venture Investor
    OrbiMed
  • Venture Investor
    Polaris Venture Partners
  • Venture Investor
    QVT Fund LP
  • Venture Investor
    Sutter Hill Ventures
  • Venture Investor
    Venrock

By posting a comment, you agree to our terms and conditions.